12:00 AM
Mar 17, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Profectus BioSciences Inc.

Baltimore, Md.

Technology: Vaccines against conserved regions of HIV envelope proteins and small molecule NF-kappa B modulators to...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >